×

Monoclonal antibodies to human bladder and ureter cancers and method

  • US 4,643,971 A
  • Filed: 12/30/1983
  • Issued: 02/17/1987
  • Est. Priority Date: 03/11/1983
  • Status: Expired due to Fees
First Claim
Patent Images

1. Method for differentiating between normal and malignant human transitional bladder cells and between invasive and non-invasive bladder transitional cell carcinom as which comprises contacting a shed or intact human bladder transitional cell specimen with at least two of the monoclonal antibodies selected from the group consisting of T16, T23, T43, J233, JP165, T101, Om5, Om37, J143, T87, T138 and T110 and detecting malignant transitional bladder cells and distinguishing between invasive and non-invasive malignant transitional bladder cells reacting with said antibodies.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×